These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26941095)

  • 21. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
    Saha A; O'Connor RS; Thangavelu G; Lovitch SB; Dandamudi DB; Wilson CB; Vincent BG; Tkachev V; Pawlicki JM; Furlan SN; Kean LS; Aoyama K; Taylor PA; Panoskaltsis-Mortari A; Foncea R; Ranganathan P; Devine SM; Burrill JS; Guo L; Sacristan C; Snyder NW; Blair IA; Milone MC; Dustin ML; Riley JL; Bernlohr DA; Murphy WJ; Fife BT; Munn DH; Miller JS; Serody JS; Freeman GJ; Sharpe AH; Turka LA; Blazar BR
    J Clin Invest; 2016 Jul; 126(7):2642-60. PubMed ID: 27294527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft.
    Han FF; Fan H; Wang ZH; Li GR; Lv YL; Gong LL; Liu H; He Q; Liu LH
    Transpl Immunol; 2014 Aug; 31(2):81-6. PubMed ID: 24952299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
    Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of programmed death ligand 1 and Kupffer cell in immune regulation after orthotopic liver transplantation in rats.
    Gong J; Cao D; Chen Y; Li J; Gong J; Zeng Z
    Int Immunopharmacol; 2017 Jul; 48():8-16. PubMed ID: 28458101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis.
    Ishibashi N; Watanabe T; Kanehira M; Watanabe Y; Hoshikawa Y; Notsuda H; Noda M; Sakurada A; Ohkouchi S; Kondo T; Okada Y
    Surg Today; 2018 Jul; 48(7):726-734. PubMed ID: 29546496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
    Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
    Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility.
    Qian C; Guo H; Chen X; Shi A; Li S; Wang X; Pan J; Fang C
    J Diabetes Res; 2018; 2018():1614683. PubMed ID: 30534571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of PD-L1 Gene Polymorphisms and Interactions with Cooking with Solid Fuel Exposure on Tuberculosis.
    Tang K; Wang J; Zhong H; Wang Q; Li Z; Wu C; An R; Lin Y; Tan H; Chen L; Wang M; Chen M
    Public Health Genomics; 2024; 27(1):74-82. PubMed ID: 38735285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer.
    Shi X; Zhang X; Li J; Zhao H; Mo L; Shi X; Hu Z; Gao J; Tan W
    Cancer Lett; 2017 Oct; 406():27-35. PubMed ID: 28797844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses.
    Starke A; Lindenmeyer MT; Segerer S; Neusser MA; Rüsi B; Schmid DM; Cohen CD; Wüthrich RP; Fehr T; Waeckerle-Men Y
    Kidney Int; 2010 Jul; 78(1):38-47. PubMed ID: 20393451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients.
    Dornieden T; Wilde B; Korth J; Werner K; Horn PA; Witzke O; Lindemann M
    J Immunol Res; 2019; 2019():3926175. PubMed ID: 30931336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
    Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1 and PD-L1 Up-regulation Promotes T-cell Apoptosis in Gastric Adenocarcinoma.
    Chiu YM; Tsai CL; Kao JT; Hsieh CT; Shieh DC; Lee YJ; Tsay GJ; Cheng KS; Wu YY
    Anticancer Res; 2018 Apr; 38(4):2069-2078. PubMed ID: 29599324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the cytokine polymorphisms in correlation to rejection and graft survival in renal allograft donors and recipients from a homogenous Saudi population.
    Gaafar A; Iqniebi A; Sheereen A; Eldali A; Turpeinen H; Adra C; Al Meshari K; Al Hussein K
    Transpl Immunol; 2014 Jan; 30(1):34-9. PubMed ID: 24316141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.
    Krönig H; Kremmler L; Haller B; Englert C; Peschel C; Andreesen R; Blank CU
    Eur J Haematol; 2014 Mar; 92(3):195-203. PubMed ID: 24175978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells.
    Stefanski AL; Wiedemann A; Reiter K; Hiepe F; Lino AC; Dörner T
    Arthritis Rheumatol; 2019 Sep; 71(9):1539-1544. PubMed ID: 30919595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-Regulation of Donor Dendritic Cell PD-L1 Expression Reduced Recipient Lymphocyte Activation and Proliferation In Vitro.
    Li T; Ma R; Zhu JY
    Transplant Proc; 2021 Mar; 53(2):716-723. PubMed ID: 33551184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of innate and acquired immune mechanisms in clinical intestinal transplant rejection.
    Mathew JM; Tryphonopoulos P; DeFaria W; Ruiz P; Miller J; Barrett TA; Tzakis AG; Kato T
    Transplantation; 2015 Jun; 99(6):1273-81. PubMed ID: 25539468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.